How can pharmacists best support patients with chronic lymphocytic leukaemia?

The PJ Pod

Over the last decade, the development of targeted therapies has significantly changed the way that chronic lymphocytic leukaemia (CLL) is treated. Survival and life expectancy has improved, and this patient cohort is living and receiving treatment for longer than ever before. These changes have meant that the involvement of pharmacists across all sectors in the treatment of CLL patients has also evolved significantly. In this episode of The PJ Pod, Caitlin Killen, assistant clinical editor, speaks to a patient who has been living with CLL for 17 years, as well as with two pharmacists involved in the care of CLL patients, to understand how pharmacists can best support patients with CLL. Many thanks to expert patient Anthea Holland; Catherine Parbutt, consultant pharmacist for cancer services, The Leeds Teaching Hospitals NHS Trust; and Tejal Gorasia, principal cancer pharmacist, Milton Keynes University Hospital NHS Foundation Trust, for their expertise. This episode was produced by Geoff Marsh.